View recent articles in Biopharma News
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover »
The biopharma world is here. Endpoints News is an independent news organization, reporting on the »
News on the biopharmaceutical manufacturing industry, focusing on biologics, technology, upstream »
Breaking news from the biotech, clinical research and pharmaceutical industries. BioSpace is The »
The future of mRNA, J&J's vaccine adcomm, Merck's $1.85B autoimmune bet and more 
Roivant Dives Deeper into AI with $450 Million Buy of Silicon Therapeutics 
Research Roundup: Compound Reverses ALS Nerve Damage and More 
Field Trip Health’s New Psilocybin Research Facility Probes the Secrets of Shrooms 
BioSpace Movers & Shakers, Feb. 26 
Artiva Raises $120 Million to Advance Pipeline of Allogeneic NK Cell Therapies 
FDA panel backs J&J's coronavirus vaccine, clearing way for shot's authorization 
J&J adcomm live blog: Committee votes 22-0 to recommend an FDA OK for the J&J vaccine, setting up 3rd US Covid-19 jab 
Bluebird reveals new details on cancer cases in gene therapy trial 
J&J adcomm live blog: Will variants impede a long-sought goal for Covid-19 research? 
Gossamer pushes ahead with failed asthma drug; Cullgen gets $50M Series B for protein degraders 
Perceptive's fourth — yes, fourth — SPAC jumps to Nasdaq as the blank check tree continues to ripen 
FDA advisers meet to review J&J's one-shot coronavirus vaccine 
Sarepta wins FDA approval of another drug for rare muscular dystrophy 
Merck to buy autoimmune drugmaker for $2B 
Pfizer and BioNTech start trialing booster shot for COVID-19 vaccine 
FDA says J&J COVID-19 vaccine is effective and safe 
Moderna announces capital investments to boost COVID-19 vaccine production 
Moderna to take new variant-specific COVID-19 vaccine into Phase 1 trials 
Coming of Phage: Clinical trial underscores safety of technology battling E. coli triggered UTIs